Introduction
Genital herpes simplex virus (HSV) infection is the commonest cause of genital ulceration in women in the United Kingdom. One of the most difficult questions asked by patients with genital HSV infection is whether they can be infectious in the absence of symptoms. Most clinicians answer that this phenomenon, so called "asymptomatic shedding", has been observed but is believed to be rare and that there are no data to predict when it might occur. The term "asymptomatic shedding" is open to misinterpretation. It may be used to indicate isolation of HSV from a clinically obvious lesion of which the patient is unaware: or from a lesion, such as a cervical lesion, that is accessible to the doctor but not the patient; or from an intact, apparently normal, epithelial surface -that is, inapparent shedding.
There have been several studies of asymptomatic shedding in pregnant women,'-3 but other groups of women have been less intensively investigated. 
HERPES SIMPLEX VIRUS ISOLATION
Swabs were placed in 1 ml of viral transport medium containing nutrient broth, penicillin (1000 IU/ml), streptomycin (1000 IU/ml), and ampicillin (50 mg/ml), and were processed immediately or stored at -700C. A 0-2 ml volume of the sample was inoculated into two tubes containing monolayers of human embryonic lung fibroblasts (MRC5, Flow Laboratories, Rickmansworth, England), which were incubated at 370C. The monolayers were observed daily for cytopathic effect. A specimen was considered to be negative if a characteristic change had not occurred after seven days. Monolayers exhibiting a cytopathic effect were harvested by scraping the cells into the medium, and the suspensions were frozen at -70°C until used for virus typing.
Results
Though none of the patients believed that they had ever infected a sexual partner, all of them had reduced the incidence of sexual intercourse since HSV infection had been diagnosed. On detailed questioning this was found to be due to a fear of infecting their uninfected sexual partner, though the extent to which guilt feelings and other psychological manifestations of HSV infection also caused this was uncertain. The motivation of these women to be studied in such an intensive way, however, was directly related to their worries about asymptomatic shedding.
During the study period of 234 days and 88 patient visits, four of the women had no clinical or virological evidence of recurrences of HSV infection. The other four, however, each yielded at least one positive HSV culture, all of which were confirmed as HSV type 2. The details of these patients are presented below. CASE 3 One patient (case 3) had two reccurrences. On day 8, despite her being asymptomatic, colposcopic examination of her right labium major showed, erythema and vesicles from which HSV was isolated. The following day symptoms developed, and ulceration was visible to the naked eye. Viral culture was again positive on day 10. On day 13, though HSV was not isolated from the routine cervical sweep, a colposcopically directed swab of an ulcerated area (figure) gave positive results. The virus was not isolated from the vulva or cervix on day 15, by which time the vulval lesion was a scab and the cervical ulcer had healed. On day 19 of the study the patient was asymptomatic, but a urethral swab was positive for HSV.
Thus, this patient had one vulval and cervical recurrence, which was initially asymptomatic but became symptomatic, and one asymptomatic inapparent urethral recurrence. CASE 5 One patient (case 5) had two recurrences. On day 12 vulval erythema was seen colposcopically; by day 14 the patient had become symptomatic, the lesion being visible to the naked eye and culture positive. The virus was not isolated after day 17 from the typical ulcers, which had healed by day 20. On day 27 a tiny vulval sore, which was culture positive, was seen colposcopically. At this visit the patient had no genital symptoms, but felt that she had experienced the prodromal symptoms of an attack for the previous two days. These symptoms, intermittent headache and backache, had disappeared on the day of the examination. She reported that these warnings were usually, but not inevitably, followed by vulval sores. By the next visit on day 29, the sores had crusted and the virus was not isolated. Thus this patient had one symptomatic vulval recurrence and one apparently asymptomatic vulval recurrence during the study period. CASE 6 One patient (case 6) had one recurrence at three sites consecutively. On day 13 a virus positive colposcopically apparent cervical lesion was seen, but the patient was asymptomatic. Two days later a virus negative vaginal ulcer was seen and a symptomatic vulval recurrence, which was virus positive, began. By day 18 the cervical, vaginal, and vulval sites had healed and the virus was not isolated from them, but on the right buttock a virus positive vesicular eruption appeared, which caused considerable pain and healed after seven days. (table  III) had a sensitivity of 85 7% and a specificity of 92-4% for predicting whether specimens from the urogenital tract would be virus positive. Furthermore, the positive predictive value was 78-3% and the negative predictive value was 95 4%. This association was valid for all anatomical sites sampled. All patients had negative serological tests for syphilis, negative cultures for N gonorrhoeae, and normal cervical cytology within three months after the study.
Discussion
The data on which to base the counselling of women with HSV infection about the problem of asymptomatic shedding are inadequate. We set out to obtain information about the patients in our study group to make individual counselling possible. Non-lesional prodromes have been described by Sacks in a study that relied totally on patient observations of whether a prodrome was followed by genital ulceration.'4 One patient (case 5) in our study had a prodrome that was followed by an episode of asymptomatic vulval shedding of HSV from a microscopic vulval ulcer that could be seen only with the colposcope. It is thus essential for any investigators intending to comment on the incidence of non-lesional prodromes to make regular examinations, and if possible use colposcopy, to ascertain whether lesions really do occur.
One patient (case 8) was apparently infectious on nine of her 11 clinic visits, the virus being cultured from a variety of urogenital sites. Our options for management were either barrier contraception, prophylactic acyclovir, or counselling and careful follow up. The patient opted for continued follow up, as she had ended the relationship with her regular boyfriend and had no current sexual partner. She stopped shedding virus two weeks after the study period. Subsequent viral cultures at visits twice weekly for two months have not yielded a positive culture. We intend to continue to see her as often as she agrees and to manage her according to her needs.
The effect of this patient's frequent asymptomatic shedding on her risk of developing cervical intraepithelial neoplasia is not known. Though HSV infection of the cervix has been shown to increase the susceptibility of cervical cells to undergo atypical transformation,"5 additional stimuli are needed to promote carcinogenesis. As sperm may act as such a stimulus,'6 it is evident that women who have asymptomatic recurrent cervical HSV infection are at most risk because they will be having intercourse while the cervix is infected. Thus barrier contraception, as well as reducing the risk of transmission of HSV, might also reduce the woman's risk of developing cervical neoplasia.
